91 related articles for article (PubMed ID: 9035126)
1. Novartis licenses gene therapy to avoid monopoly.
Glaser V
Nat Biotechnol; 1997 Feb; 15(2):118-9. PubMed ID: 9035126
[No Abstract] [Full Text] [Related]
2. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
[TBL] [Abstract][Full Text] [Related]
3. [The biosafety of the HSV-TK/GCV gene therapy in five cases of recurrent glioblastoma multiforme].
Adachi N; Könü DL; Frei K; Yonekawa Y
No Shinkei Geka; 2000 Nov; 28(11):965-74. PubMed ID: 11127592
[TBL] [Abstract][Full Text] [Related]
4. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
[TBL] [Abstract][Full Text] [Related]
5. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
[TBL] [Abstract][Full Text] [Related]
6. Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy.
Hlavatý J; Hlubinová K; Bies J; Altaner C
Neoplasma; 1999; 46(6):329-34. PubMed ID: 10732860
[TBL] [Abstract][Full Text] [Related]
7. [The HSV-TK/GCV gene therapy in five cases of recurrent glioblastoma multiforme].
Adachi N; Könü DL; Frei K; Yonekawa Y
No Shinkei Geka; 2000 Oct; 28(10):865-71. PubMed ID: 11070906
[TBL] [Abstract][Full Text] [Related]
8. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
[TBL] [Abstract][Full Text] [Related]
9. [Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene].
Quillien V; Heresbach Le Berre N; Dufour T; Denais A; Guegan Y; Ferry N; Bloin V
Bull Cancer; 1997 Nov; 84(11):1047-52. PubMed ID: 9536986
[TBL] [Abstract][Full Text] [Related]
10. [French clinical trials of gene therapy with "suicide gene"].
Jeanteur P
Bull Cancer; 1999 Feb; 86(2):137-8. PubMed ID: 10094522
[No Abstract] [Full Text] [Related]
11. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
Greco O; Powell TM; Marples B; Joiner MC; Scott SD
Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381
[TBL] [Abstract][Full Text] [Related]
12. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
Mizuno M; Ryuke Y; Yoshida J
Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
[TBL] [Abstract][Full Text] [Related]
13. Novartis reclaims tk technology.
Johnson E
Nat Biotechnol; 1997 Mar; 15(3):211. PubMed ID: 9062913
[No Abstract] [Full Text] [Related]
14. Cure following gene therapy for recurrent glioblastoma multiforme?
Karabatsou K; Bernstein M
Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
[TBL] [Abstract][Full Text] [Related]
15. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
17. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
[TBL] [Abstract][Full Text] [Related]
18. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
[TBL] [Abstract][Full Text] [Related]
19. [In vitro model for the suicide gene therapy of AFP-producing gastric cancer using HSVtk gene under control of AFP promoter].
Nakaya H
Hokkaido Igaku Zasshi; 2003 May; 78(3):203-9. PubMed ID: 12795172
[No Abstract] [Full Text] [Related]
20. Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death.
Griffin JL; Lehtimäki KK; Valonen PK; Gröhn OH; Kettunen MI; Ylä-Herttuala S; Pitkänen A; Nicholson JK; Kauppinen RA
Cancer Res; 2003 Jun; 63(12):3195-201. PubMed ID: 12810648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
